Diary - News
All news Novasep Invests 4 Million Euros to Expand Its Cryogenic Production Capacity
Lyon, France, October 24, 2017 – Novasep, a leading supplier of services and technologies for the life sciences industry, today announced a €4M investment to expand cGMP capacity for clinical and commercial supply of APIs at its Chasse-sur-Rhône (FR) facility.
The investment includes the installation of a new cGMP cryogenic production line, capable of operating at temperatures as low as -80°C. It is equipped with a 4m3 Hastelloy reactor, filter drier and clean room.
The investment also includes an expansion of the cGMP pilot-plant capabilities with the addition of a new stream comprising a 400L Hastelloy reactor, filter drier and clean room. This will add flexible small-scale manufacturing capacity and reinforce the site’s capability to handle both clinical development needs and low volume APIs.